| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.5 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.5 | 3e-16 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.44 | 4e-18 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.43 | 9e-21 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.42 | 2e-18 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.36 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.35 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-19 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.33 | 3e-23 |